Phase II multicenter trial of oral Quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/sézary syndrome.
Child, F Ortiz-Romero, P Alvarez, R Bagot, M Stadler, R Weichenthal, M Alves, R Quaglino, P Beylot-Barry, M
Child, F
Ortiz-Romero, P
Alvarez, R
Bagot, M
Stadler, R
Weichenthal, M
Alves, R
Quaglino, P
Beylot-Barry, M
Citations
Altmetric:
Abstract
Quisinostat is a hydroxamate, second-generation, orally available pan-histone deacetylase inhibitor.
Description
Date
2016-02-02
Publisher
Collections
Keywords
Type
Article
Citation
Phase II multicenter trial of oral Quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/sézary syndrome. 2016: Br J Dermatol